509
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Bronchoalveolar fluid and plasma inflammatory biomarkers in contemporary ARDS patients

, , , , , , , & show all
Pages 352-359 | Received 10 Nov 2017, Accepted 02 Feb 2019, Published online: 04 Mar 2019

References

  • Acute Respiratory Distress Syndrome Network, Brower R.G., et al., 2000. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The New England journal of medicine, 342, 1301–1308.
  • Aisiku, I.P., et al., 2016. Plasma cytokines IL-6, IL-8, and IL-10 are associated with the development of acute respiratory distress syndrome in patients with severe traumatic brain injury. Critical care, 20, 288.
  • Allen, T.C., and Kurdowska, A., 2014. Interleukin 8 and acute lung injury. Archives of pathology & laboratory medicine, 138 (2), 266–269.
  • Bautista, E., et al., 2013. Angiogenic and inflammatory markers in acute respiratory distress syndrome and renal injury associated to A/H1N1 virus infection. Experimental and molecular pathology, 94 (3), 486–492.
  • Bernard, G.R., et al., 1994. The American-European Consensus Conference on ARDS. Definitions. American journal of respiratory and critical care medicine, 149 (3), 818–824.
  • Bhatia, M., and Moochhala, S., 2004. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. The journal of pathology, 202 (2), 145–156.
  • Brower, R.G., et al., 2004. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. The New England journal of medicine, 351, 327–336.
  • Calfee, C.S., et al., 2007. Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Critical care medicine, 35 (10), 2243–2250.
  • Calfee, C.S., et al., 2008. Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax, 63 (12), 1083–1089.
  • Codorean, E., et al., 2010. Correlation of XMAP and ELISA cytokine profiles; development and validation for immunotoxicological studies in vitro. Roumanian archives of microbiology and immunology, 69, 13–19.
  • Cook, D., et al., 2011. Dalteparin versus unfractionated heparin in critically ill patients. The New England journal of medicine, 364, 1305–1314.
  • Cook, D.J., et al., 1996. Stress ulcer prophylaxis in critically ill patients. Resolving discordant Meta-analyses. Jama, 275, 308–314.
  • Debley, J.S., et al., 2007. Methods to improve measurement of cysteinyl leukotrienes in exhaled breath condensate from subjects with asthma and healthy controls. The Journal of allergy and clinical immunology, 120 (5), 1216–1217.
  • Donnelly, S.C., et al., 1996. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Annals of internal medicine, 125 (3), 191–196.
  • Eisner, M.D., et al., 2003. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax, 58 (11), 983–988.
  • Erickson, S.E., et al., 2009. Recent trends in acute lung injury mortality: 1996-2005. Critical care medicine, 37 (5), 1574–1579.
  • Gadek, J.E., et al., 1999. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Critical care medicine, 27 (8), 1409–1420.
  • Goodman, R.B., et al., 1996. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. American journal of respiratory and critical care medicine, 154 (3), 602–611.
  • Goodman, R.B., et al., 2003. Cytokine-mediated inflammation in acute lung injury. Cytokine and growth factor reviews, 14 (6), 523–535.
  • Guerin, C., et al., 2013. Prone positioning in severe acute respiratory distress syndrome. The New England journal of medicine, 368, 2159–2168.
  • Haegens, A., et al., 2007. Airway epithelial NF-kappaB activation modulates asbestos-induced inflammation and mucin production in vivo. Journal of immunology, 178 (3), 1800–1808.
  • Hudson, L.D., 1995. New therapies for ARDS. Chest, 108 (2 Suppl), 79S–91S.
  • Knaus, W.A., et al., 1985. APACHE II: a severity of disease classification system. Critical care medicine, 13 (10), 818–829.
  • Kofoed, K., et al., 2006. Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology. Clinical chemistry, 52 (7), 1284–1293.
  • Krupa, A., et al., 2004. Proinflammatory activity of anti-IL-8 autoantibody:IL-8 complexes in alveolar edema fluid from patients with acute lung injury. American journal of physiology. Lung cellular and molecular physiology, 286 (6), L1105–L1113.
  • Le Gall, J.R., Lemeshow, S., and Saulnier, F., 1993. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. Jama: the journal of the American medical association, 270 (24), 2957–2963.
  • Lee, K.S., et al., 2008. Evaluation of bronchoalveolar lavage fluid from ARDS patients with regard to apoptosis. Respiratory medicine, 102 (3), 464–469.
  • Loo, B.M., Marniemi, J., and Jula, A., 2011. Evaluation of multiplex immunoassays, used for determination of adiponectin, resistin, leptin, and ghrelin from human blood samples, in comparison to ELISA assays. Scandinavian journal of clinical and laboratory investigation, 71 (3), 221–226.
  • Maca, J., et al., 2017. Past and present ARDS mortality rates: a systematic review. Respiratory care, 62 (1), 113–122.
  • Martin, T.R., et al., 1989. Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. Journal of clinical investigation, 84 (5), 1609–1619.
  • Matthay, M.A., and Zemans, R.L., 2011. The acute respiratory distress syndrome: pathogenesis and treatment. Annual review of pathology: Mechanisms of disease, 6 (1), 147–163.
  • Matute-Bello, G., et al., 1999. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). Journal of immunology, 163 (4), 2217–2225.
  • Mukhopadhyay, S., Hoidal, J.R., and Mukherjee, T.K., 2006. Role of TNFalpha in pulmonary pathophysiology. Respiratory research, 7, 125.
  • Murray, J.F., et al., 1988. An expanded definition of the adult respiratory distress syndrome. American review of respiratory disease, 138 (3), 720–723.
  • Oppenheim, J.J., et al., 1991. Properties of the novel proinflammatory supergene “intercrine” cytokine family. Annual review of immunology, 9 (1), 617–648.
  • Pacht, E.R., et al., 2003. Enteral nutrition with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical care medicine, 31 (2), 491–500.
  • Parsons, P.E., et al., 1997. Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at-risk patients. American journal of respiratory and critical care medicine, 155 (4), 1469–1473.
  • Parsons, P.E., et al., 2005. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Critical care medicine, 33 (1), 1–6.
  • Peters-Golden, M., and Henderson, W.R., Jr., 2007. Leukotrienes. The New England journal of medicine, 357 (18), 1841–1854.
  • Phua, J., et al., 2009. Has mortality from acute respiratory distress syndrome decreased over time? American journal of respiratory and critical care medicine, 179 (3), 220–227.
  • Pronovost, P., et al., 2006. An intervention to decrease catheter-related bloodstream infections in the ICU. The New England journal of medicine, 355 (26), 2725–2732.
  • Ranieri, V.M., et al., 1999. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. Jama, 282 (1), 54–61.
  • Rice, T.W., et al., 2012. Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. Jama, 307 (8), 795–803.
  • Rivers, E., et al., 2001. Early goal-directed therapy in the treatment of severe sepsis and septic shock. The new England journal of medicine, 345 (19), 1368–1377.
  • Rubenfeld, G.D., et al., 2005. Incidence and outcomes of acute lung injury. The new England journal of medicine, 353 (16), 1685–1693.
  • Sittipunt, C., et al., 2001. Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome. American journal of respiratory and critical care medicine, 163 (2), 503–510.
  • Stapleton, R.D., et al., 2005. Causes and timing of death in patients with ARDS. Chest, 128 (2), 525–532.
  • Stapleton, R.D., et al., 2011. A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Critical care medicine, 39 (7), 1655–1662.
  • Suratt, B.T., et al., 2009. Plasma granulocyte colony-stimulating factor levels correlate with clinical outcomes in patients with acute lung injury. Critical care medicine, 37 (4), 1322–1328.
  • Wang, L.S., et al., 2012. Comparison of xMAP and ELISA assays for detecting cerebrospinal fluid biomarkers of Alzheimer's disease. Journal of Alzheimer's disease, 31 (2), 439–445.
  • Ware, L.B., Conner, E.R., and Matthay, M.A., 2001. von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury. Critical care medicine, 29 (12), 2325–2331.
  • Ware, L.B., and Matthay, M.A., 2000. The acute respiratory distress syndrome. The New England journal of medicine, 342 (18), 1334–1349.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.